McKesson Corporation
MCK
Xếp hạng trong cổ phiếu
#191
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Giá cổ phiếu
$1,004.22
Vốn hóa thị trường
$117.08B
Thay đổi (1 ngày)
-0.10%
Thay đổi (1 năm)
27.76%
Quốc gia
US
Giao dịch McKesson Corporation (MCK)
Danh mục
Healthcare
EPS của McKesson Corporation (MCK)
EPS tính đến June 2026 TTM: $37.53
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của McKesson Corporation, EPS hiện tại của công ty (TTM) là $37.53. Vào cuối năm 2024, công ty có EPS là $22.54, giảm so với EPS năm 2023 là $25.23.
Lịch sử EPS của McKesson Corporation từ 2000 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $37.53 | 45.13% |
| 2025 | $25.86 | 14.73% |
| 2024 | $22.54 | -10.66% |
| 2023 | $25.23 | 245.14% |
| 2022 | $7.31 | -127.05% |
| 2021 | $-27.02 | -643.66% |
| 2020 | $4.97 | 2,823.53% |
| 2019 | $0.17 | -46.88% |
| 2018 | $0.32 | -98.61% |
| 2017 | $22.95 | 133.71% |
| 2016 | $9.82 | 54.16% |
| 2015 | $6.37 | 15.61% |
| 2014 | $5.51 | -3.50% |
| 2013 | $5.71 | 0.18% |
| 2012 | $5.70 | 22.58% |
| 2011 | $4.65 | -1.06% |
| 2010 | $4.70 | 57.19% |
| 2009 | $2.99 | -12.06% |
| 2008 | $3.40 | 11.11% |
| 2007 | $3.06 | 24.39% |
| 2006 | $2.46 | -564.15% |
| 2005 | $-0.53 | -123.77% |
| 2004 | $2.23 | 16.15% |
| 2003 | $1.92 | 30.61% |
| 2002 | $1.47 | -964.71% |
| 2001 | $-0.17 | -106.61% |
| 2000 | $2.57 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| - | - |
US
|
|
| $7.27 | -80.63% |
US
|
|
| - | - |
US
|
|
| $0.04 | -99.88% |
AU
|
|
| $3.46 | -90.78% |
US
|
